Search results
Sep 22, 2023 · In August 2023, CDC recommended a new RSV immunization called nirsevimab to protect babies and some toddlers from severe RSV during the RSV season. In July 2023, CDC recommended RSV vaccine for adults ages 60 and over, using shared clinical decision-making. This means these individuals should talk to their healthcare provider about whether RSV ...
Mar 1, 2024 · Percents of weekly COVID-19-associated hospitalizations, by age group — COVID-NET, March 1, 2020–January 27, 2024. The proportion of hospitalizations caused by each of these viruses in the 2022–2023 season varied by age group. Among children <5 years RSV caused the most hospitalizations.
People also ask
Will there be additional respiratory disease outlooks in 2023-2024?
Is the National per capita hospitalization rate declining in 2023-2024?
What is the peak hospitalization rate compared to 2022-2023?
What happened to CSTE cases in 2020?
- Overview
- Explore deeper data
•The amount of respiratory illness (fever plus cough or sore throat) causing people to seek healthcare is elevated across many areas of the country. This week, 27 jurisdictions experienced high or very high activity compared to 25 jurisdictions last week.
•Nationally, emergency department visits with diagnosed COVID-19, influenza, and RSV are decreasing.
•Influenza test positivity remained stable nationally but is increasing in the Northeastern, Mid-Atlantic, Midwest, and Central parts of the country. COVID-19 and RSV test positivity decreased compared to the previous week.
•Nationally, COVID-19 wastewater viral activity levels, which reflect both symptomatic and asymptomatic infections, remain at high levels, particularly in the South, but are trending downward.
Reported on Friday, February 16th, 2024.
Level of Respiratory Illness Activity
State Map of Outpatient Respiratory Illness Activity
Outpatient Illness and Viral Surveillance
State Map of Emergency Department Use for COVID-19
COVID-19 Testing, Hospitalization, and Death Trends
Weekly U.S. Influenza Surveillance Report
RSV Testing Trends in the U.S.
Feb 8, 2024 · Outlook. CDC expects the upcoming fall and winter respiratory disease season will likely have a similar number of total hospitalizations compared to last year. As with last year, the number of hospitalizations is expected to be higher than that experienced prior to the COVID-19 pandemic, when severe disease was caused primarily by the influenza ...
Population estimates for incidence rates are July 1st, 2020, estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for April 1, 2010, to July 1, 2020, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American ...
Apr 4, 2023 · The threshold for a seasonal epidemic was set at 3% RSV-positive PCR test results (not based on a moving average). The figure is a line chart showing percentage of polymerase chain reaction test results positive for respiratory syncytial virus in the United States during July 2017–February 2023.
Dec 29, 2020 · Contact: Media Relations. (404) 639-3286. In 2020 CDC worked around the clock – and around the globe – to protect Americans from health threats. While the COVID-19 pandemic has dominated the news, a number of other public health and scientific advancements are worth highlighting. “This has been a year of challenges, but also of innovation ...
